Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P P Roy

Showing results (21-30 of 107) with videos related to

Pageof 11
Sort By:
The Hillside Journal of Clinical Psychiatry|January 1, 1985
Lithium intolerance disproved by blind clinical trialC H Kellner, P P Roy-Byrne, P W Gold
The Journal of Clinical Psychiatry|March 1, 1989
Valproate in anxiety and withdrawal syndromesP P Roy-Byrne, N G Ward, P J Donnelly
The American Journal of Psychiatry|May 1, 1990
Irritable bowel syndrome and psychiatric illnessE A Walker, P P Roy-Byrne, W J Katon
Archives of General Psychiatry|September 1, 1986
Effects of one night's sleep deprivation on mood and behavior in panic disorder. Patients with panic disorder compared with depressed patients and normal controlsP P Roy-Byrne, T W Uhde, R M Post
Brain Research|September 11, 1995
Effect of muscimol on haloperidol-induced alteration of neurotensin gene expression in the striatum and nucleus accumbens in the ratK P Decker, P P Roy-Byrne, K M Merchant
Anxiety|January 1, 1996
Long-term course and outcome in panic disorder: a naturalistic follow-up studyD S Cowley, S N Flick, P P Roy-Byrne
Hospital & Community Psychiatry|November 1, 1988
Recent advances in the psychopharmacological treatment of anxiety disordersR B Lydiard, P P Roy-Byrne, J C Ballenger
Journal of Clinical Psychopharmacology|October 1, 1988
Neuroendocrine effects of diazepam in normal subjects following brief painful stressP P Roy-Byrne, S C Risch, T W Uhde
SAR and QSAR in Environmental Research|March 2, 2026
Computational exploration and discovery of dual EGFR-CDK2 kinase inhibitors: AI-ML powered bioisosteric design, 3D QSAR, docking, DFT and ADMET analysis of novel phthalimide derivativesB W Matore, A Murmu, P P Roy, et al.
The Journal of Clinical Psychiatry|February 4, 1998
Determinants of pharmacologic treatment failure in panic disorderD S Cowley, E H Ha, P P Roy-Byrne
Pageof 11

Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
The Hillside Journal of Clinical Psychiatry|January 1, 1985
Lithium intolerance disproved by blind clinical trialC H Kellner, P P Roy-Byrne, P W Gold
The Journal of Clinical Psychiatry|March 1, 1989
Valproate in anxiety and withdrawal syndromesP P Roy-Byrne, N G Ward, P J Donnelly
The American Journal of Psychiatry|May 1, 1990
Irritable bowel syndrome and psychiatric illnessE A Walker, P P Roy-Byrne, W J Katon
Archives of General Psychiatry|September 1, 1986
Effects of one night's sleep deprivation on mood and behavior in panic disorder. Patients with panic disorder compared with depressed patients and normal controlsP P Roy-Byrne, T W Uhde, R M Post
Brain Research|September 11, 1995
Effect of muscimol on haloperidol-induced alteration of neurotensin gene expression in the striatum and nucleus accumbens in the ratK P Decker, P P Roy-Byrne, K M Merchant
Anxiety|January 1, 1996
Long-term course and outcome in panic disorder: a naturalistic follow-up studyD S Cowley, S N Flick, P P Roy-Byrne
Hospital & Community Psychiatry|November 1, 1988
Recent advances in the psychopharmacological treatment of anxiety disordersR B Lydiard, P P Roy-Byrne, J C Ballenger
Journal of Clinical Psychopharmacology|October 1, 1988
Neuroendocrine effects of diazepam in normal subjects following brief painful stressP P Roy-Byrne, S C Risch, T W Uhde
SAR and QSAR in Environmental Research|March 2, 2026
Computational exploration and discovery of dual EGFR-CDK2 kinase inhibitors: AI-ML powered bioisosteric design, 3D QSAR, docking, DFT and ADMET analysis of novel phthalimide derivativesB W Matore, A Murmu, P P Roy, et al.
The Journal of Clinical Psychiatry|February 4, 1998
Determinants of pharmacologic treatment failure in panic disorderD S Cowley, E H Ha, P P Roy-Byrne
Pageof 11